KCT0004411
Completed
未知
Effectiveness and safety of electroacupuncture and its cotreatment with electronic moxibustion in the treatment of patients with moderate benign prostatic hyperplasia using alpha blocker : An assessor-blinded, randomized controlled clinical trial
ConditionsDiseases of The genitoruinary system
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Diseases of The genitoruinary system
- Sponsor
- Korea Institute of Oriental Medicine
- Enrollment
- 78
- Status
- Completed
- Last Updated
- 5 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\) Man over 50 years old and under 79 years old who is diagnosed with prostatic hyperplasia and is taking alpha blocker
- •2\) Total International Prostate Symptom Score (Total IPSS) is 8 or more and 19 or less
- •3\) Able and willing to comply with the intervention and follow\-up evaluation
- •4\) Able to provide written informed consent
Exclusion Criteria
- •1\) Subjects who are diagnosed with prostatic hyperplasia and are taking medications other than alpha blockers (5\-alpha reductase inhibitors, anticholinergic drugs, antidiuretic hormones, etc.) for treatment
- •2\) Subjects whose Prostate\-Specific Antigen (PSA) values are greater than 4ng/mL (subjects with a PSA \= 4ng/mL are required to have a prostate biopsy negative for malignance)
- •3\) Subjects with the clinical evidence of neurogenic bladder, urethral stricture, bladder calculus, acute/chronic renal failure, urinary tract infection or other urology diseases except BPH
- •4\) Subjects with clinical evidence of genito\-urinary malignant tumors including prostate or bladder cancer
- •5\) Subjects who have history of prostate surgery or who are scheduled prostate surgery
- •6\) Subjects who had AUR
- •7\) Subjects with clinical evidence of renal or hepatic impairment
- •8\) Subjects with clinically significant urinalysis findings or hematuria with urinalysis
- •9\) Subjects who use pacemaker
- •10\) Severe underlying disease (uncontrolled hypertention, cardiovascular disease, or malignant tumor) requiring active therapy
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Early Phase 1
Safety and effectiveness of electroacupuncture in the treatment of postoperative gastrointestinal dysfunction in patients with perioperative esophageal cancer: a prospective, randomized, and controlled clinical trialITMCTR2024000118The First Affiliated Hospital of Naval Medical University
Recruiting
Not Applicable
Effectiveness and Safety of Electro-acupuncture for the Patients with Gastroesophageal Reflux DiseaseDiseases of the digestive systemKCT0001653Kyung Hee University Oriental Medical Center60
Not yet recruiting
Not Applicable
The efficacy and safety of electroacupuncture in the treatment of Alzheimer's diseaseITMCTR2100005087Guang'anmen Hospital, China Academy of Chinese Medicine Sciences
Recruiting
Not Applicable
Clinical trial to evaluate efficacy and safety of Electroacupuncture and Acupuncture in Postmenopausal Women with overactive bladderDiseases of The genitoruinary systemKCT0003912Dongguk University Ilsan Oriental Hospital147
Recruiting
Not Applicable
The clinical evaluation of electroacupuncture combined with mindfulness meditation in the weight managementOverweightObesityAlternative and Complementary Medicine - Other alternative and complementary medicineACTRN12618000964213RMIT University165